Metastatic Breast Cancer Part One: A Research Update
The latest clinical trial findings and their impact on today’s available treatment options. Novel therapies in the research pipeline and the role they may play in the future of care. The latest understanding of what may cause metastases and how we can prevent it in the future.
- the latest clinical trial findings and their impact on today’s available treatment options
- novel therapies in the research pipeline and the role they may play in future care
- the latest understanding of what may cause metastasis and how we might prevent it in the future
About Our Speaker
Linda T. Vahdat, MD is a professor of medicine, director of the Breast Cancer Research Program and chie of the Solid Tumor Service at Weill Cornell Medical College. Her expertise is in the treatment of breast cancer and she is involved in the conceptualization, design and conduct of phase I through III clinical trials, primarily in high-risk adjuvant and metastatic breast cancer.
She has been actively involved in the American Society of Clinical Oncology since 1994, participating on several committees including the Education Committee and Health Services Research Committee. She also served as co-chair of the ASCO Breast Cancer Symposium for 2010. Dr. Vahdat has been a member of the executive board of Cancer Care, Inc. since 2005 and was honored with their Physician of the Year award in 2002 and with the Humanitarian Award by Cancer Care of Connecticut in 2007, for her volunteer work with the organization. She is a reviewer for a number of peer-reviewed journals including Journal of Clinical Oncology and Clinical Cancer Research.